NLK and colon carcinoma: For example, overexpression of wildtype NLK in colon carcinoma cells, boosted programmed cell death through phosphorylation of CBP, and hence, suppression of the transcriptional activity of AP-1, Smad, and p53, all of which use CBP as a co-activator [4], [26].